Molecular hallmarks of cognitive resilience and resistance in Alzheimer's disease: Insights from excitatory and inhibitory neurons

This study reveals cellular and molecular features of cognitive resilience, highlighting the roles of excitatory and inhibitory neurons, protein folding pathways, and protective signaling networks. Our observations expose that the excitatory-inhibitory balance, which is disrupted in AD, is maintained in resilience. Our findings provide a foundation for leveraging resilience mechanisms to develop targeted therapies for AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_096285
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular hallmarks of cognitive resilience and resistance in Alzheimer's disease: Insights from excitatory and inhibitory neurons

Doo Yeon Kim, Athanasios Ploumakis, Isabel Castanho, Christoph Lange et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Molecular hallmarks of cognitive resilience and resistance in Alzheimer's disease: Insights from excitatory and inhibitory neurons

Doo Yeon Kim, Athanasios Ploumakis, Isabel Castanho, Christoph Lange, Sarah L. Morgan, Nikolaos Kalavros, Carles A. Boix, R E Tanzi, Saloni Shah, Lars Bertram, Giulia Pegoraro, Bartholomew White, Pourya Naderi Yeganeh, Winston Hide, Manolis Kellis, Li‐Huei Tsai, David A. A. Bennett, Hansruedi Mathys, Dmitry Prokopenko, Larisa M. Soto
article en

Abstract

This study reveals cellular and molecular features of cognitive resilience, highlighting the roles of excitatory and inhibitory neurons, protein folding pathways, and protective signaling networks. Our observations expose that the excitatory-inhibitory balance, which is disrupted in AD, is maintained in resilience. Our findings provide a foundation for leveraging resilience mechanisms to develop targeted therapies for AD.

Alzheimer s & DementiaVol. 21(S1)
Broad Institute (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), Queen Mary University of London (GB), University of Pittsburgh (US), University of Oslo (NO), University of Exeter (GB), Massachusetts General Hospital (US), Rush University (US), Massachusetts Institute of Technology (US), University of Lübeck (DE)
Openalex Percentile: Top 34%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.